Skip to main content
Top
Published in: Pediatric Radiology 5/2018

01-05-2018 | Original Article

Importance of whole-body imaging with complete coverage of hands and feet in alveolar rhabdomyosarcoma staging

Authors: Monika Scheer, Tobias Dantonello, Peter Brossart, Dagmar Dilloo, Lothar Schweigerer, Simone Feuchtgruber, Monika Sparber-Sauer, Christian Vokuhl, Stefan S. Bielack, Thomas Klingebiel, Ewa Koscielniak, Thekla von Kalle, on behalf of the Cooperative Weichteilsarkom Studiengruppe (CWS)

Published in: Pediatric Radiology | Issue 5/2018

Login to get access

Abstract

Background

Alveolar rhabdomyosarcoma commonly arises in the extremities and is characterized by aggressive biology and high frequency of metastases. Whole-body imaging is increasingly employed in pediatric oncology but not recommended as standard in the staging of soft-tissue sarcomas.

Objective

After observing patients with a large symptomatic alveolar rhabdomyosarcoma lesion and a smaller silent lesion in the more distal part of an extremity we sought to estimate the frequency of this constellation.

Materials and Methods

We retrospectively evaluated the data of prospectively registered paediatric patients (age <21 years) with alveolar rhabdomyosarcoma in the SoTiSaR (Soft Tissue Sarcoma Registry) of the Cooperative Weichteilsarkom Studiengruppe (CWS) 09/2011–04/2015 with regard to whole-body imaging.

Results

Seventy-five patients were eligible. Images of 57 patients had been submitted for reference consultation, including 80 whole-body examinations in 36 patients. Among them were 5 patients (14%, 95% confidence interval 3–25%) who had been diagnosed because of a symptomatic lesion while an additional silent lesion in the distal part of an extremity had remained unnoticed and had only been detected by later whole-body imaging. It is noteworthy that in 42 (53%) of all 80 whole-body examinations, the hands and feet had been only partially covered or completely excluded.

Conclusion

In alveolar rhabdomyosarcoma silent lesions can be overlooked when the distal parts of the limbs are not thoroughly examined and not completely covered by imaging. Missing them influences treatment decisions and prognosis. Our results should be considered when evaluating the potential role of whole-body imaging in rhabdomyosarcoma.
Literature
1.
go back to reference Klingebiel T, Boos J, Beske F et al (2008) Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial. Pediatr Blood Cancer 50:739–745CrossRefPubMed Klingebiel T, Boos J, Beske F et al (2008) Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial. Pediatr Blood Cancer 50:739–745CrossRefPubMed
2.
go back to reference Scheer M, Dantonello T, Hallmen E et al (2016) Primary metastatic synovial sarcoma: experience of the CWS study group. Pediatr Blood Cancer 63:1198–1206CrossRefPubMed Scheer M, Dantonello T, Hallmen E et al (2016) Primary metastatic synovial sarcoma: experience of the CWS study group. Pediatr Blood Cancer 63:1198–1206CrossRefPubMed
3.
go back to reference Oberlin O, Rey A, Lyden E et al (2008) Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. J Clin Oncol 26:2384–2389CrossRefPubMedPubMedCentral Oberlin O, Rey A, Lyden E et al (2008) Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. J Clin Oncol 26:2384–2389CrossRefPubMedPubMedCentral
4.
go back to reference Weigel BJ, Lyden E, Anderson JR et al (2016) Intensive multiagent therapy, including dose-compressed cycles of ifosfamide/etoposide and vincristine/doxorubicin/cyclophosphamide, irinotecan, and radiation, in patients with high-risk rhabdomyosarcoma: a report from the Children's Oncology Group. J Clin Oncol 34:117–122CrossRefPubMed Weigel BJ, Lyden E, Anderson JR et al (2016) Intensive multiagent therapy, including dose-compressed cycles of ifosfamide/etoposide and vincristine/doxorubicin/cyclophosphamide, irinotecan, and radiation, in patients with high-risk rhabdomyosarcoma: a report from the Children's Oncology Group. J Clin Oncol 34:117–122CrossRefPubMed
5.
go back to reference Scheer M, Dantonello T, Hallmen E et al (2016) Synovial sarcoma recurrence in children and young adults. Ann Surg Oncol 23:618–626CrossRefPubMed Scheer M, Dantonello T, Hallmen E et al (2016) Synovial sarcoma recurrence in children and young adults. Ann Surg Oncol 23:618–626CrossRefPubMed
6.
go back to reference The ESMO/European Sarcoma Network Working Group (2014) Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25, Issue suppl_3, 1, iii102–iii112 The ESMO/European Sarcoma Network Working Group (2014) Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25, Issue suppl_3, 1, iii102–iii112
7.
go back to reference Hays DM, Newton W Jr, Soule EH et al (1983) Mortality among children with rhabdomyosarcomas of the alveolar histologic subtype. J Pediatr Surg 18:412–417CrossRefPubMed Hays DM, Newton W Jr, Soule EH et al (1983) Mortality among children with rhabdomyosarcomas of the alveolar histologic subtype. J Pediatr Surg 18:412–417CrossRefPubMed
8.
go back to reference Koscielniak E, Rodary C, Flamant F et al (1992) Metastatic rhabdomyosarcoma and histologically similar tumors in childhood: a retrospective European multi-center analysis. Med Pediatr Oncol 20:209–214CrossRefPubMed Koscielniak E, Rodary C, Flamant F et al (1992) Metastatic rhabdomyosarcoma and histologically similar tumors in childhood: a retrospective European multi-center analysis. Med Pediatr Oncol 20:209–214CrossRefPubMed
9.
10.
go back to reference Casanova M, Meazza C, Favini F et al (2009) Rhabdomyosarcoma of the extremities: a focus on tumors arising in the hand and foot. Pediatr Hematol Oncol 26:321–331CrossRefPubMed Casanova M, Meazza C, Favini F et al (2009) Rhabdomyosarcoma of the extremities: a focus on tumors arising in the hand and foot. Pediatr Hematol Oncol 26:321–331CrossRefPubMed
11.
go back to reference Miller DV, Coffin CM, Zhou H (2004) Rhabdomyosarcoma arising in the hand or foot: a clinicopathologic analysis. Pediatr Dev Pathol 7:361–369CrossRefPubMed Miller DV, Coffin CM, Zhou H (2004) Rhabdomyosarcoma arising in the hand or foot: a clinicopathologic analysis. Pediatr Dev Pathol 7:361–369CrossRefPubMed
12.
go back to reference Harms D (1995) Alveolar rhabdomyosarcoma: a prognostically unfavorable rhabdomyosarcoma type and its necessary distinction from embryonal rhabdomyosarcoma. Curr Top Pathol 89:273–296CrossRefPubMed Harms D (1995) Alveolar rhabdomyosarcoma: a prognostically unfavorable rhabdomyosarcoma type and its necessary distinction from embryonal rhabdomyosarcoma. Curr Top Pathol 89:273–296CrossRefPubMed
13.
go back to reference Ben Arush M, Minard-Colin V, Mosseri V et al (2015) Does aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma? Eur J Cancer 51:193–201CrossRefPubMed Ben Arush M, Minard-Colin V, Mosseri V et al (2015) Does aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma? Eur J Cancer 51:193–201CrossRefPubMed
15.
go back to reference Sorensen PH, Lynch JC, Qualman SJ et al (2002) PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. J Clin Oncol 20:2672–2679CrossRefPubMed Sorensen PH, Lynch JC, Qualman SJ et al (2002) PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. J Clin Oncol 20:2672–2679CrossRefPubMed
16.
go back to reference Armitage P, Berry G (ed) (1994) Inferences from proportions. In: Statistical methods in medical research, 3rd edn. Blackwell Scientific Publications, Oxford, pp 118–125 Armitage P, Berry G (ed) (1994) Inferences from proportions. In: Statistical methods in medical research, 3rd edn. Blackwell Scientific Publications, Oxford, pp 118–125
17.
go back to reference Boellaard R, Delgado-Bolton R, Oyen WJ et al (2015) FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 42:328–354CrossRefPubMed Boellaard R, Delgado-Bolton R, Oyen WJ et al (2015) FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 42:328–354CrossRefPubMed
18.
go back to reference Franzius C, Stauss J, Pfluger T et al (2010) Procedure guidelines for whole-body 18F-FDG PET and PET/CT in children with malignant diseases. Nuklearmedizin 49:225–233CrossRefPubMed Franzius C, Stauss J, Pfluger T et al (2010) Procedure guidelines for whole-body 18F-FDG PET and PET/CT in children with malignant diseases. Nuklearmedizin 49:225–233CrossRefPubMed
19.
go back to reference Stauss J, Franzius C, Pfluger T et al (2008) Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology. Eur J Nucl Med Mol Imaging 35:1581–1588CrossRefPubMed Stauss J, Franzius C, Pfluger T et al (2008) Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology. Eur J Nucl Med Mol Imaging 35:1581–1588CrossRefPubMed
21.
go back to reference Roberge D, Hickeson M, Charest M et al (2009) Utility of total body FDG PET/CT imaging in the initial staging of soft-tissue sarcoma. J Clin Oncol 27:10531 Roberge D, Hickeson M, Charest M et al (2009) Utility of total body FDG PET/CT imaging in the initial staging of soft-tissue sarcoma. J Clin Oncol 27:10531
22.
go back to reference Eutsler EP, Khanna G (2016) Whole-body magnetic resonance imaging in children: technique and clinical applications. Pediatr Radiol 46:858–872CrossRefPubMed Eutsler EP, Khanna G (2016) Whole-body magnetic resonance imaging in children: technique and clinical applications. Pediatr Radiol 46:858–872CrossRefPubMed
24.
go back to reference Davis JT, Kwatra N, Schooler GR (2016) Pediatric whole-body MRI: a review of current imaging techniques and clinical applications. J Magn Reson Imaging 44:783–793CrossRefPubMed Davis JT, Kwatra N, Schooler GR (2016) Pediatric whole-body MRI: a review of current imaging techniques and clinical applications. J Magn Reson Imaging 44:783–793CrossRefPubMed
25.
go back to reference Ponisio MR, McConathy J, Laforest R et al (2016) Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma. Pediatr Radiol 46:1258–1268CrossRefPubMedPubMedCentral Ponisio MR, McConathy J, Laforest R et al (2016) Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma. Pediatr Radiol 46:1258–1268CrossRefPubMedPubMedCentral
26.
go back to reference Benusiglio PR, Brugieres L, Caron O (2016) Whole-Body MRI screening in children with Li-Fraumeni and other cancer predisposition syndromes. AJR Am J Roentgenol 206:W52CrossRefPubMed Benusiglio PR, Brugieres L, Caron O (2016) Whole-Body MRI screening in children with Li-Fraumeni and other cancer predisposition syndromes. AJR Am J Roentgenol 206:W52CrossRefPubMed
27.
28.
go back to reference Schafer JF, Gatidis S, Schmidt H et al (2014) Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results. Radiology 273:220–231CrossRefPubMed Schafer JF, Gatidis S, Schmidt H et al (2014) Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results. Radiology 273:220–231CrossRefPubMed
29.
go back to reference Sher AC, Seghers V, Paldino MJ et al (2016) Assessment of sequential PET/MRI in comparison with PET/CT of pediatric lymphoma: a prospective study. AJR Am J Roentgenol 206:623–631CrossRefPubMed Sher AC, Seghers V, Paldino MJ et al (2016) Assessment of sequential PET/MRI in comparison with PET/CT of pediatric lymphoma: a prospective study. AJR Am J Roentgenol 206:623–631CrossRefPubMed
30.
go back to reference Volker T, Denecke T, Steffen I et al (2007) Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. J Clin Oncol 25:5435–5441CrossRefPubMed Volker T, Denecke T, Steffen I et al (2007) Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. J Clin Oncol 25:5435–5441CrossRefPubMed
31.
go back to reference Tateishi U, Hosono A, Makimoto A et al (2009) Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma. Ann Nucl Med 23:155–161CrossRefPubMed Tateishi U, Hosono A, Makimoto A et al (2009) Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma. Ann Nucl Med 23:155–161CrossRefPubMed
32.
go back to reference Weihkopf T, Blettner M, Dantonello T et al (2008) Incidence and time trends of soft tissue sarcomas in German children 1985-2004 — a report from the population-based German Childhood Cancer Registry. Eur J Cancer 44:432–440CrossRefPubMed Weihkopf T, Blettner M, Dantonello T et al (2008) Incidence and time trends of soft tissue sarcomas in German children 1985-2004 — a report from the population-based German Childhood Cancer Registry. Eur J Cancer 44:432–440CrossRefPubMed
33.
go back to reference Kuttesch JF Jr, Parham DM, Kaste SC et al (1995) Embryonal malignancies of unknown primary origin in children. Cancer 75:115–121CrossRefPubMed Kuttesch JF Jr, Parham DM, Kaste SC et al (1995) Embryonal malignancies of unknown primary origin in children. Cancer 75:115–121CrossRefPubMed
34.
go back to reference Pappo AS, Shapiro DN, Crist WM et al (1995) Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol 13:2123–2139CrossRefPubMed Pappo AS, Shapiro DN, Crist WM et al (1995) Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol 13:2123–2139CrossRefPubMed
35.
go back to reference Dantonello TM, Int-Veen C, Harms D et al (2009) Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults. J Clin Oncol 27:1446–1455CrossRefPubMed Dantonello TM, Int-Veen C, Harms D et al (2009) Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults. J Clin Oncol 27:1446–1455CrossRefPubMed
36.
go back to reference Asmar L, Gehan EA, Newton WA et al (1994) Agreement among and within groups of pathologists in the classification of rhabdomyosarcoma and related childhood sarcomas. Report of an international study of four pathology classifications Cancer 74:2579–2588PubMed Asmar L, Gehan EA, Newton WA et al (1994) Agreement among and within groups of pathologists in the classification of rhabdomyosarcoma and related childhood sarcomas. Report of an international study of four pathology classifications Cancer 74:2579–2588PubMed
Metadata
Title
Importance of whole-body imaging with complete coverage of hands and feet in alveolar rhabdomyosarcoma staging
Authors
Monika Scheer
Tobias Dantonello
Peter Brossart
Dagmar Dilloo
Lothar Schweigerer
Simone Feuchtgruber
Monika Sparber-Sauer
Christian Vokuhl
Stefan S. Bielack
Thomas Klingebiel
Ewa Koscielniak
Thekla von Kalle
on behalf of the Cooperative Weichteilsarkom Studiengruppe (CWS)
Publication date
01-05-2018
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Radiology / Issue 5/2018
Print ISSN: 0301-0449
Electronic ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-017-4066-8

Other articles of this Issue 5/2018

Pediatric Radiology 5/2018 Go to the issue